tPA fast by GUSTO.
作者信息
Horton R
出版信息
Lancet. 1993 May 8;341(8854):1188. doi: 10.1016/0140-6736(93)91011-a.
PMID:8098084
Abstract
摘要
相似文献
1
tPA fast by GUSTO.GUSTO研究中tPA快速给药方案
Lancet. 1993 May 8;341(8854):1188. doi: 10.1016/0140-6736(93)91011-a.
2
3
The GUSTO trial: is the open-artery hypothesis proven?
Ann Pharmacother. 1994 Jan;28(1):97-8. doi: 10.1177/106002809402800118.
4
Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.美国及其他国家急性心肌梗死患者管理与治疗结果的差异。GUSTO试验结果。全球应用链激酶和组织型纤溶酶原激活剂治疗闭塞冠状动脉研究。
JAMA. 1995;273(20):1586-91. doi: 10.1001/jama.273.20.1586.
5
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.一项比较四种急性心肌梗死溶栓策略的国际随机试验。
N Engl J Med. 1993 Sep 2;329(10):673-82. doi: 10.1056/NEJM199309023291001.
6
Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators.个体患者溶栓治疗的选择：临床模型的建立。GUSTO-I研究人员。
Am Heart J. 1997 Jun;133(6):630-9. doi: 10.1016/s0002-8703(97)70164-9.
7
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators.
Circulation. 1996 Sep 15;94(6):1233-8. doi: 10.1161/01.cir.94.6.1233.
8
Six-month survival in 20,891 patients with acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. GISSI-2 and International Study Group. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto.20891例急性心肌梗死患者被随机分为接受阿替普酶和链激酶治疗（加或不加肝素），对其进行六个月生存率的研究。GISSI - 2和国际研究小组。意大利心肌梗死生存研究组。
Eur Heart J. 1992 Dec;13(12):1692-7.
9
10
[A randomized study of streptokinase and recombinant tissue plasminogen activator, with and without heparin, in patients with acute myocardial infarction. The results of GISSI-2/International tPA/SK Mortality Trial].急性心肌梗死患者中链激酶与重组组织型纤溶酶原激活剂联合或不联合肝素的随机研究。GISSI-2/国际tPA/SK死亡率试验结果
Ugeskr Laeger. 1991 Oct 7;153(41):2880-3.
引用本文的文献
1
Alteplase: a pharmacoeconomic evaluation of its use in the management of myocardial infarction.阿替普酶：对其用于心肌梗死治疗的药物经济学评估
Pharmacoeconomics. 1995 Nov;8(5):428-59. doi: 10.2165/00019053-199508050-00006.
2
Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants.心脏保护疗法——用于治疗高血压、高脂血症、血栓栓塞、心律失常、绝经后状态以及作为抗氧化剂的药物。
Postgrad Med J. 1994 May;70(823):329-43. doi: 10.1136/pgmj.70.823.329.
Zotero 插件